Merck Historical Cash Flow
| 0QAH Stock | USD 98.40 0.20 0.20% |
Analysis of Merck cash flow over time is an excellent tool to project Merck Company future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Other Cashflows From Financing Activities of 9.9 B or Depreciation of 3.8 B as it is a great indicator of Merck ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Merck Company latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Merck Company is a good buy for the upcoming year.
Merck |
About Merck Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Merck balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Merck's non-liquid assets can be easily converted into cash.
Merck Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by Merck Company to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Merck operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in Merck Company financial statement analysis. It represents the amount of money remaining after all of Merck Company operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from Merck's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Merck Company current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Merck's Change To Netincome is quite stable compared to the past year. Change To Liabilities is expected to rise to about 408.5 M this year, although the value of Investments are projected to rise to (12 B).
| 2022 | 2023 | 2024 | 2025 (projected) | Dividends Paid | 7.0B | 7.4B | 8.6B | 7.3B | Depreciation | 3.9B | 3.9B | 4.5B | 3.8B |
Merck cash flow statement Correlations
Click cells to compare fundamentals
Merck Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Merck cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (895M) | (674M) | (161M) | (816M) | (938.4M) | (985.3M) | |
| Investments | 1.7B | 1.0B | (5.0B) | (14.1B) | (12.7B) | (12.0B) | |
| Change In Cash | (1.8B) | 14M | 4.6B | (5.9B) | (5.3B) | (5.0B) | |
| Depreciation | 3.2B | 3.1B | 3.9B | 3.9B | 4.5B | 3.8B | |
| Dividends Paid | 6.2B | 6.6B | 7.0B | 7.4B | 8.6B | 7.3B | |
| Capital Expenditures | 4.4B | 4.4B | 4.4B | 3.9B | 4.4B | 4.5B | |
| Total Cash From Operating Activities | 10.2B | 14.1B | 19.1B | 13.0B | 15.0B | 15.4B | |
| Change To Account Receivables | (1.0B) | (2.0B) | (644M) | (1.1B) | (1.0B) | (1.1B) | |
| Net Income | 7.1B | 13.0B | 14.5B | 365M | 328.5M | 312.1M | |
| Total Cash From Financing Activities | (2.8B) | 2.6B | (9.1B) | (4.8B) | (5.5B) | (5.8B) | |
| End Period Cash Flow | 8.2B | 8.2B | 12.8B | 6.9B | 6.2B | 7.3B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Merck Company. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.